Columbia residents Saturday raised nearly $45,000 in a fundraiser walk to end amyotrophic lateral sclerosis, or ALS. Some people got together in teams to raise large sums of money to donate, while ...
The early-stage pipeline for amyotrophic lateral sclerosis drugs exploded last year. After ALS R&D notched 28 new trial ...
A new Northwestern University study using patient nervous tissue and lab-grown human neurons has uncovered how a key disease ...
In the MIROCALS trial, Gilbert Bensimon and colleagues1 showed that low-dose interleukin-2 (IL-2) added to riluzole did not significantly reduce mortality in an unadjusted analysis of patients with ...
We thank Yutaka Shimazu for his insightful comments. We agree that our positive findings1–4 highlight the urgent need for further work on biomarkers of neuronal damage and immune mechanisms in ...
Testing showed that Gonzalez’ ALS was caused by a mutation in the SOD1 gene (Super Oxide Dismutase 1), which meant she was ...
Despite modern imaging and genetic testing, diagnosing amyotrophic lateral sclerosis (ALS) remains challenging, particularly ...
Researchers developed a cell-free DNA blood test that accurately distinguishes ALS from other neurological diseases and tracks progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback